Ignite Creation Date:
2024-05-06 @ 3:56 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04810338
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2021-03-17
Brief Title:
Study Evaluating the Pronostic Value of Vascular Refilling Rate on Mortality in Chronic Kidney Disease Patients on Dialysis
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Evaluation of the Pronostic Value of Vascular Refilling Rate on Mortality in Chronic Kidney Disease Patients on Dialysis Stage 5D
Status:
COMPLETED
Status Verified Date:
2022-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REMVAMIR
Brief Summary:
Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis Stage 5D during an observational period of 3 years
the prognostic value of vascular refilling rate on mortality and on the occurrence of i cardiovascular events and ii hospitalization number
the prognostic value of interdialytic weight gain on mortality and on the occurrence of i cardiovascular events and ii hospitalization number
the prognostic value of perdialytic weight loss on mortality and on the occurrence of i cardiovascular events and ii hospitalization number
the prognostic value of vascular refilling rate on mortality and on the occurrence of i cardiovascular events and ii hospitalization number
the prognostic value of interdialytic weight gain on mortality and on the occurrence of i cardiovascular events and ii hospitalization number
the prognostic value of perdialytic weight loss on mortality and on the occurrence of i cardiovascular events and ii hospitalization number
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None